The Limited Times

Now you can see non-English news...

Elon Musk got permission for Neuralink to test its brain implants in humans

2023-05-27T12:30:13.001Z

Highlights: Elon Musk's company, Neuralink, has received approval from the FDA to do human studies of its brain implants. The company will focus on recruiting volunteers for its first clinical study, although it has not yet opened enrollment and promises that it will announce more information on this question soon. The FDA had initially been reluctant to approve it and expressed concern about the possible overheating of the implant, which includes microwires in brain tissue. The regulator changed its position and will allow the company specialized in the development of interfaces of this type to continue with its plans.


It's closer to using it on people. Studies point to human prototypes.


Elon Musk is closer to being able to implant a computer into a human brain. Neuralink, the neurotechnology company he owns, announced that it has received approval from the U.S. Food and Drug Administration (FDA) to do human studies of its brain implants.

"We are pleased to announce that we have received FDA approval to launch our first human clinical study!" the company announced Thursday on its Twitter account.

Neuralink's tweet.

Tesla CEO Elon Musk said the launch following FDA approval for its first human clinical trial is "an important first step" for its technology, which aims to allow brains to interact directly with computers.

"This is an important first step that will allow our technology to one day help many people," the Californian company explained on its Twitter account.

Neuralink's next steps

Now, the company will focus on recruiting volunteers for its first clinical study, although it has not yet opened enrollment and promises that it will announce more information on this question soon.

The FDA had initially been reluctant to approve it and expressed concern about the possible overheating of the implant, which includes microwires in brain tissue. The US regulator argued that they could result in the leakage of chemical elements from the implant into the brain mass.

Neuralink.

Until now, the company founded by Elon Musk had only done a few trials on monkeys. The results convinced the company, but not specialized organizations.

In a meeting organized by The Wall Street Journal, the tycoon said that the system was "safe and reliable"; however, the Physicians Committee for Responsible Medicine accused the researchers of subjecting the monkeys to unlawful mistreatment and "extreme suffering."

Musk has been demanding authorization from the FDA for human trials for months. In early December, he went so far as to say that Neuralink was ready to perform brain implants on humans within six months. The regulator changed its position and will allow the company specialized in the development of interfaces of this type to continue with its plans.

Their chips have a therapeutic purpose. Its function is to read brain activity to be able to transmit orders that help restore some brain functions severely damaged after a heart attack, amyotrophic lateral sclerosis or tetraplegia. The goal is for these people to have the ability to control their computers and mobile devices with their thoughts.

Until now, brain implants were developed in only one direction: from the brain to the outside, where a computer processed the signals. But the Neuralink project wants to end this paradigm, also moving information in the other direction, to the brain.

With information from La Vanguardia.

See also

Microsoft now says its new intelligence reasons like a human

The creator of ChatGPT revealed what the most common use that users give to artificial intelligence

Source: clarin

All tech articles on 2023-05-27

You may like

Trends 24h

Tech/Game 2024-03-27T18:05:36.686Z

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.